| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-08 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |